October | VOL.1.1 | HYDERABAD |
In today's changing business world, Cohance Lifesciences has taken a momentous step forward by initiating ESG (Environmental, Social, and Governance) reporting across its platform, marking the beginning of a new chapter in its commitment to sustainability and ethical business practices. This significant move, launched in April 2023, represents Cohance's dedication to transparency, accountability, and a profound desire to cultivate trust and confidence amongst its valued stakeholders, including employees, investors, and the communities it serves.
Cohance has forged a dynamic partnership with KPMG India for its expertise in ESG reporting. They are assisting Cohance's three-year ESG journey FY 22-25 by developing the reports, performing the gap analysis and Stakeholder Engagement and Materiality Assessment. Impressively, the progress for the first FY 2022-23 report has reached a 97% completion rate, paving the way for publishing the company's first inaugural ESG report by November 2023.
Cohance is resolutely dedicated to minimising its environmental footprint by implementing robust waste recycling programs. The company actively promotes and practices the responsible use of water, striving to reduce consumption, promote water recycling, and safeguard this precious resource sustainably throughout its units.
Cohance is actively exploring strategies to diminish its dependence on fossil fuels, a notable contributor to environmental degradation, in line with its commitment to a cleaner and more sustainable energy source. Lowering energy consumption not only serves as a cost-effective measure but also significantly reduces the company's carbon footprint, reinforcing its dedication to environmental preservation.
Cohance is committed to improving the world by addressing ESG concerns as part of the company's dedication to transparency. Together, as the Cohance community, we work towards a more sustainable and responsible future.